But the medications effects reach far beyond glucose control
In laboratory settings, Semaglutide research often focuses on GLP-1 receptor activity, metabolic signalling, peptide stability, receptor interaction and comparison with other incretin-based research compounds
FDA recently determined that GLP-1 drugs no longer met the criteria for a shortage
Christiansen points to a recent BMJ study involving more than 600,000 veterans that explored the relationship between GLP-1 use and addiction outcomes
In this case, consider asking your doctor about Wegovy (semaglutide approved for weight loss), which some plans cover for obesity treatment, or explore cash-pay options
How Does Wegovy Work for Weight Loss